Evidence map›Paper›PMID 42573426›Full record

ArticleActa dermato-venereologica2026

Persistent Symmetrical Drug-related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Metoprolol: Resolution via Beta-blocker Switch.

Tim Schricker, Nikolaus Möhlenkamp, Franziska Hübner, Ulrike Raap, Nikolaos Patsinakidis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta dermato-venereologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tim SchrickerDepartment of Dermatology and Allergology, Klinikum Oldenburg, Oldenburg, Germany; Division of Experimental Allergy and Immunodermatology, Faculty of Medical Health and Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany. schricker.tim@klinikum-oldenburg.de.ORCID 0000-0002-3338-7489
Nikolaus MöhlenkampDepartment of Dermatology and Allergology, Klinikum Oldenburg, Oldenburg, Germany; Division of Experimental Allergy and Immunodermatology, Faculty of Medical Health and Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Franziska HübnerDepartment of Dermatology and Allergology, Klinikum Oldenburg, Oldenburg, Germany; Division of Experimental Allergy and Immunodermatology, Faculty of Medical Health and Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Ulrike RaapDepartment of Dermatology and Allergology, Klinikum Oldenburg, Oldenburg, Germany; Division of Experimental Allergy and Immunodermatology, Faculty of Medical Health and Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.
Nikolaos PatsinakidisDepartment of Dermatology and Allergology, Klinikum Oldenburg, Oldenburg, Germany; Division of Experimental Allergy and Immunodermatology, Faculty of Medical Health and Sciences, Carl von Ossietzky University of Oldenburg, Oldenburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42573426
PMCPMC13455170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.